All Clinical Trials
View all active clinical trials around the US.
A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of "Intermediate Fit" Comparing Upfront Thr...
TRIPLET INDUCTION + 1 OR 2-DRUG MAINTENANCE
Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multiple Myeloma Patients
IBERDOMIDE VS. OBSERVATION POST IDE-CEL CAR-T
Blinded Reference Set for Multicancer Early Detection Blood Tests
EARLY DETECTION BLOOD TESTS
Untreated / Newly Diagnosed Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.
A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of "Intermediate Fit" Comparing Upfront Thr...
TRIPLET INDUCTION + 1 OR 2-DRUG MAINTENANCE
Blinded Reference Set for Multicancer Early Detection Blood Tests
EARLY DETECTION BLOOD TESTS
Late Relapse Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multiple Myeloma Patients
IBERDOMIDE VS. OBSERVATION POST IDE-CEL CAR-T
Smoldering Myeloma
No active clinical trials
Monoclonal Gammopathy of Undetermined Significance (MGUS)
No active clinical trials